Determination of Zolmitriptan and its Primary Metabolite, n-Desmethy-Zolmitriptan, in Rat Plasma by LC-MS-MS
Authors:
Open Access
- 21 June 2012
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Chromatographic Science
- Vol. 51 (1) , 59-64
Abstract
The objective of this work was to develop a simple, cost effective, rugged and rapid method for the simultaneous estimation of zolmitriptan (ZP) and its active metabolite n-desmethy-zolmitriptan (DZP) in rat plasma to meet the requirement for biological sample analysis. The simple liquid–liquid extraction employed in the present work gave consistent and reproducible recoveries for both the analytes. A mixture of methanol–20 mM ammonium acetate–formic acid (60:40:0.1, v/v/v) was used as mobile phase at a flow rate of 0.3 mL/min. The temperature of column and autosampler were maintained at 40 and 4°C, respectively. The chromatographic run time of each sample was 3.0 min. The limit of quantification was low enough to monitor at least four half-lives of ZP and DZP concentrations with good intra-assay and inter-assay reproducibility for the quality controls. According to the results of all the validation parameters, the method can also be useful for pharmacokinetics study of ZP and for therapeutic drug monitoring in humans with the desired precision and accuracy.Keywords
This publication has 8 references indexed in Scilit:
- Determination of rizatriptan in human plasma by liquid chromatographic–eletrospray tandem mass spectrometry: application to a pharmacokinetic studyBiomedical Chromatography, 2005
- Quantification of zolmitriptan in plasma by high-performance liquid chromatography–electrospray ionization mass spectrometryJournal of Chromatography B, 2004
- High-performance liquid chromatographic analysis of zolmitriptan in human plasma using fluorescence detectionJournal of Pharmaceutical and Biomedical Analysis, 2004
- Validation and application of a high‐performance liquid chromatography/tandem mass spectrometry assay for sumatriptan in human plasmaBiomedical Chromatography, 2003
- Review of zolmitriptan and its clinical applications in migraineExpert Opinion on Pharmacotherapy, 2002
- Determination of antimigraine compounds rizatriptan, zolmitriptan, naratriptan and sumatriptan in human serum by liquid chromatography/electrospray tandem mass spectrometryRapid Communications in Mass Spectrometry, 2000
- The absolute bioavailability and effect of food on the pharmacokinetics of zolmitriptan in healthy volunteersBritish Journal of Clinical Pharmacology, 1998
- The pharmacodynamics and pharmacokinetics of the 5HT1B/1D-agonist zolmitriptan in healthy young and elderly men and women*Clinical Pharmacology & Therapeutics, 1998